Patents Assigned to BULLDOG PHARMACEUTICALS, INC.
  • USES OF ANTI-HER3 ANTIBODIES FOR TREATING CANCER
    Publication number: 20170190788
    Abstract: Provided herein are methods of treating cancer comprising administering antibodies and antigen-binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms, and dosing regimens for related monotherapies and combination therapies.
    Type: Application
    Filed: September 10, 2015
    Publication date: July 6, 2017
    Applicant: BULLDOG PHARMACEUTICALS, INC.
    Inventors: Theresa Marie LAVALLEE, Carolyn Fowler SIDOR, Diego ALVARADO